NO20063410L - Probiotiske tablettformuleringer - Google Patents

Probiotiske tablettformuleringer

Info

Publication number
NO20063410L
NO20063410L NO20063410A NO20063410A NO20063410L NO 20063410 L NO20063410 L NO 20063410L NO 20063410 A NO20063410 A NO 20063410A NO 20063410 A NO20063410 A NO 20063410A NO 20063410 L NO20063410 L NO 20063410L
Authority
NO
Norway
Prior art keywords
zone
organism
probiotic
micro
probiotic micro
Prior art date
Application number
NO20063410A
Other languages
English (en)
Other versions
NO340908B1 (no
Inventor
Kristian Lund Henriksen
Helene Mathilda Mortensen
Marianne Winning
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30776514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063410(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of NO20063410L publication Critical patent/NO20063410L/no
Publication of NO340908B1 publication Critical patent/NO340908B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

En probiotisk tablett som omfatter en probiotisk mikroorganisme og andre ernæringsmessig aktive ingredienser i to soner, en første sone som omfatter nevnte probiotiske mikroorganisme og fortrinnsvis selen, og en andre sone som omfatter minst en nevnte annen aktiv ingrediens slik som jern, andre mineraler og vitamin B6 holdt separert fra den probiotiske mikroorganismen av nevnte første sone, vannaktiviteten i nevnte probiotiske mikroorganisme inneholdende første sone er ikke mer enn 0,2 og vanninnholdet av nevnte tablett er så mye som 3% ved vekt. God levedyktighet av mikroorganismene er oppnådd til tross for det relativt høye totale fuktighetsinnholdet.
NO20063410A 2003-12-24 2006-07-24 Probiotiske tablettformuleringer NO340908B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0330009.2A GB0330009D0 (en) 2003-12-24 2003-12-24 Probiotic tablet formulations
PCT/EP2004/014545 WO2005063200A2 (en) 2003-12-24 2004-12-21 Probiotic tablet formulations

Publications (2)

Publication Number Publication Date
NO20063410L true NO20063410L (no) 2006-09-22
NO340908B1 NO340908B1 (no) 2017-07-10

Family

ID=30776514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063410A NO340908B1 (no) 2003-12-24 2006-07-24 Probiotiske tablettformuleringer

Country Status (15)

Country Link
US (2) US10172793B2 (no)
EP (1) EP1699474B2 (no)
CN (1) CN1913905B (no)
AT (1) ATE453397T1 (no)
AU (1) AU2004308632B2 (no)
CA (1) CA2551581A1 (no)
DE (1) DE602004024924D1 (no)
DK (1) DK1699474T4 (no)
EA (1) EA011321B1 (no)
ES (1) ES2336680T5 (no)
GB (1) GB0330009D0 (no)
NO (1) NO340908B1 (no)
PL (1) PL1699474T5 (no)
UA (1) UA87296C2 (no)
WO (1) WO2005063200A2 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
EA014825B1 (ru) 2005-09-29 2011-02-28 Мерк Патент Гмбх Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
AU2012244263B2 (en) * 2005-10-12 2015-09-17 Genencor International, Inc. Stable, durable granules with active agents
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US20080241805A1 (en) 2006-08-31 2008-10-02 Q-Track Corporation System and method for simulated dosimetry using a real time locating system
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CN101259278B (zh) * 2008-04-21 2010-06-02 黄芝芳 一种含抑菌剂的多种水溶性维生素的药物组合物及其制备方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2210593A3 (en) * 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettable formulations of vitamin A and derivatives thereof
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR101102364B1 (ko) * 2009-09-18 2012-01-03 한림제약(주) 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물
US20120107395A1 (en) * 2010-11-01 2012-05-03 Viva Pharmaceutical Inc. Probiotic Soft Gel Compositions
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
DE102011122250A1 (de) * 2011-10-24 2013-04-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US9717767B2 (en) * 2014-05-12 2017-08-01 BiOWiSH Technologies, Inc. Compositions and methods for improving human health and nutrition
CA2951739C (en) * 2014-07-01 2023-09-19 Tntgamble, Inc. Bi-layer dual release probiotic tablets
CN104489646B (zh) * 2014-11-19 2016-08-31 李雅君 一种果蔬益生菌片剂及其制备方法
US10793847B2 (en) 2015-05-11 2020-10-06 Mybiotics Pharma Ltd. Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
JP7017849B2 (ja) * 2015-09-11 2022-02-09 シムライズ アーゲー 経口投与剤形
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
CN108778300A (zh) * 2015-10-07 2018-11-09 拜福丹公司 益生菌制剂
CN108347990A (zh) * 2015-10-16 2018-07-31 诺维克斯科学私人有限公司 维生素c和锌片剂的稳定组合物
CN105962376A (zh) * 2016-04-28 2016-09-28 内蒙古乌审召生态产业发展有限公司 一种具有层结构的螺旋藻片及其制备方法
RU2022101485A (ru) 2016-05-25 2022-04-27 Майбиотикс Фарма Лтд. Композиция и способы для микробиотной терапии
EP3537894A1 (en) 2016-11-10 2019-09-18 Société des Produits Nestlé S.A. Composition in powder form comprising iron and probiotic bacteria
IT201700011337A1 (it) * 2017-02-02 2018-08-02 S I I T S R L Servizio Int Imballaggi Termosaldanti Compressa multistrato per la somministrazione di magnesio
CN107821753A (zh) * 2017-11-20 2018-03-23 江苏雅博动物健康科技有限责任公司 一种宠物用益生菌颗粒制剂及其制备方法
CN111432804A (zh) * 2017-11-27 2020-07-17 帝斯曼知识产权资产管理有限公司 冻干的多微粒固体剂型
CA3096300A1 (en) 2018-05-29 2019-12-05 BiOWiSH Technologies, Inc. Compositions and methods for improving survivability of aquatic animals
US11247944B2 (en) 2019-04-12 2022-02-15 Jeffrey Hanson Robbins Potassium citrate mixture formed from a dry fertilizer and methods thereof
US11254619B2 (en) 2019-04-12 2022-02-22 Jeffrey Hanson Robbins Dry composition including effervescent agents, biostimulant, and plant nutrient
SG11202110641XA (en) 2019-04-15 2021-10-28 Inst Dinvestigacions Biomediques August Pi I Sunyer Idibaps Long-term stable live fecal microbiota composition
CN110934751B (zh) * 2019-12-31 2022-09-02 成都三勒浆药业集团四川华美制药有限公司 一种用于口腔健康的双层口含片及其制备方法
FR3125945B1 (fr) * 2021-08-03 2024-07-12 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
EP0116736B1 (en) † 1983-02-18 1987-02-25 NABISCO BRANDS, Inc. Canine biscuit containing discrete meat and/or meat by-product particles and method for making same
US4956295A (en) † 1984-05-21 1990-09-11 Chr. Hansen's Laboratory, Inc. Stabilization of dried bacteria extended in particulate carriers
JPH0780754B2 (ja) * 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US5310555A (en) † 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5885481A (en) * 1993-07-16 1999-03-23 Amoco Corporation Efficiency oxygen-scavenging compositions and articles
FR2716341B1 (fr) † 1994-02-23 1996-05-10 Gervais Danone Sa Composition alimentaire comportant un biscuit ou une coque de chocolat et un fourrage à base de produit laitier, fermenté ou non .
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
SE513815C2 (sv) 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet
US5774056A (en) * 1996-05-30 1998-06-30 Engineered Products Co. Gauge for monitoring air filters
US6083585A (en) * 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
GB2323532B (en) * 1997-03-27 2001-08-22 Bakulesh Mafatlal Khamar Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
ATE214597T1 (de) * 1997-12-19 2002-04-15 Merck Patent Gmbh Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien
US6169387B1 (en) 1997-12-22 2001-01-02 Lifecor, Inc. Battery management apparatus for portable electronic devices
EP0956858B1 (en) * 1998-04-30 2001-10-31 Renata Maria Anna Cavaliere Vesely Pharmaceutical compositions containing Lactobacillus brevis and Lactobacillus salivarius for treatment of vaginal infections
DE19819475A1 (de) † 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
CA2339643A1 (en) 1998-08-07 2000-02-17 Ganeden Biotech, Inc. Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
EP1042956B1 (en) † 1999-04-09 2006-06-21 Societe Des Produits Nestle S.A. Raw topped pizza dough
CA2281463A1 (en) 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
SE515310C2 (sv) 1999-11-25 2001-07-09 Wasa Medicals Ab Tabletter innehållande mikroorganismer och förfarande för framställning därav
US6399114B2 (en) * 2000-05-26 2002-06-04 C & D Foreman, Inc. Nutritional system for nervous system disorders
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
KR100979877B1 (ko) 2001-09-28 2010-09-02 뉴트라슈틱스 인코포레이티드 생물학적 성분의 전달 시스템
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE10206995B4 (de) 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
DE20202562U1 (de) 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
EP1344458A1 (en) † 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
DK1485463T3 (da) 2002-03-21 2008-11-10 Bifodan As Lactobacillus stamme
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
US9210945B2 (en) † 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
TR201900826T4 (tr) † 2009-08-13 2019-02-21 Kellog Co Düşük su aktiviteli gıda bağlayıcı ve bununla ilişkili metotlar.

Also Published As

Publication number Publication date
ES2336680T5 (es) 2014-01-20
AU2004308632B2 (en) 2010-07-01
NO340908B1 (no) 2017-07-10
EA011321B1 (ru) 2009-02-27
DE602004024924D1 (de) 2010-02-11
EP1699474B1 (en) 2009-12-30
ES2336680T3 (es) 2010-04-15
WO2005063200A2 (en) 2005-07-14
US10172793B2 (en) 2019-01-08
EA200601214A1 (ru) 2006-12-29
EP1699474A2 (en) 2006-09-13
CA2551581A1 (en) 2005-07-14
PL1699474T5 (pl) 2014-02-28
ATE453397T1 (de) 2010-01-15
US20190091145A1 (en) 2019-03-28
GB0330009D0 (en) 2004-01-28
UA87296C2 (en) 2009-07-10
WO2005063200A3 (en) 2005-11-24
US20070269515A1 (en) 2007-11-22
EP1699474B2 (en) 2013-10-23
PL1699474T3 (pl) 2010-06-30
CN1913905B (zh) 2010-09-08
AU2004308632A1 (en) 2005-07-14
DK1699474T4 (da) 2013-12-02
DK1699474T3 (da) 2010-04-12
CN1913905A (zh) 2007-02-14

Similar Documents

Publication Publication Date Title
NO20063410L (no) Probiotiske tablettformuleringer
Wu et al. Effect of probiotic Bacillus subtilis Ch9 for grass carp, Ctenopharyngodon idella (Valenciennes, 1844), on growth performance, digestive enzyme activities and intestinal microflora
DK0973413T3 (da) Levnedsmiddelformuleringer indeholdende lacto-N-neotetraose
ATE419829T1 (de) Extrakte aus pueraria mirifica sowie deren extraktion
HUP0301939A2 (hu) Új probiotikumok hobbiállat-eledel kompozíciókhoz
UA95967C2 (ru) Препаративная форма для локального местного введения, содержащая индоксакарб
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
NZ519980A (en) Pet food composition for treating helicobacter species in pets
DE60133581D1 (de) Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen
HUP0104782A2 (hu) Eljárás állatkedvencek aktivitásának fokozására
DE502005010277D1 (de) Teinen
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
DK2288360T3 (da) Isoleret Lactobacillus plantarum-stamme Inducia DSM21379 som probiotikum, som forøger naturlig immunitet, samt fødevareprodukter og medicinske præparater omfattende den
NO20054765L (no) Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav
TW200700074A (en) Inducer of t cell apoptosis
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
DE602005018237D1 (de) Zusammensetzung mit immunregulierenden wirkungen aus lactobacillus pentosus
FR2827774B1 (fr) Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
TW200509794A (en) Novel anthelmintic and insecticidal compositions
ATE285757T1 (de) Inaktivierte mikroorganismen, die pharmakologisch aktive substanzen enthalten
RU2001113082A (ru) Состав для изготовления драже
DE50210605D1 (de) Gewürzkrautzubereitung
EP1547608A4 (en) REMEDIES

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: FERROSAN APS, DK

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: FERROSAN APS, DK